JOIN OUR COMMITTEE The greatest gift you can give is hope. This is a very challenging climate for fundraising, and our lab is in a vulnerable position. We need to explore new ways to support our research initiatives, so we have been pulling together a passionate and dedicated Virtual Fundraising Committee. From wine
Donate in Memory of Carolyn Byington Carolyn Byington, 26, was a beloved patient of Dr. Mark Souweidane. He successfully treated her for Chiari malformation in 2008, and he remembers her and her family fondly to this day. Carolyn tragically passed away on June 10, and her family would like to support
PATIENT CARE The Children’s Brain Tumor Project Team is comprised of past and present patient families, biomedical researchers and neurosurgical clinicians working together to find a cure for pediatric brain cancers. The success of the team primarily rests in the transparency that exists between each of these three groups. Clinicians and researchers
SET-UP A FUNDRAISER The greatest gift you can give is hope. If you would like us to set up your own personalized fundraising page to honor a loved one, to support your event, or to commemorate a special occasion like a birthday or anniversary, please fill out the form here and we will
WHO WE ARE The Children's Brain Tumor Project consists of four primary investigators (PI) with expertise in pediatric neuro-oncological clinical and scientific research. Their collective research interests span a vast range of biological fields - including developmental neurobiology, immunomodulation of brain tumors, cancer metastasis, molecular biology of neuro-oncological diseases, and pharmacological engineering. The
MEET THE FAMILIES The amazing circle of love and support that formed around Elizabeth Minter during her illness made it possible to launch the Children’s Brain Tumor Project (CBTP) — a research program aimed solely at rare and inoperable brain tumors that strike children. It’s a sad fact that major funding sources
June 1, 2019 - A new research study from the CBTP lab entitled “Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy,” was published in Neuro-Oncology Advances on May 29, 2019.